| DPN | DiPhosphopyridine Nucleotide |
|---|---|
| ANT | acoustic noise test; adenine nucleotide translocator; aminonitrothiazole; anterior |
| ANT3Y | adenine nucleotide translocator 3 Y |
| DPN | dermatosis papulosa nigra; diabetic polyneuropathy; diphosphopyridine nucleotide; disabling panscler... |
| DPNH | reduced diphosphopyridine nucleotide |
| cyclic phosphoric acid | In general, a linear polymer of phosphoric acid residues in pyrophosphate linkage in which the a and ω residues are similarly linked to make one endless loop or cyclic compound, specifically, a generic term applied to compounds in which one phosphoric acid residue is esterified to two hydroxyl groups of a single carbon chain, as in adenosine 3',5'-phosphoric acid, adenosine 2',3'-phosphoric acid, etc. (05 Mar 2000) |
|---|---|
| cyclic photophosphorylation | Process by which light energy absorbed by photosystem I in the chloroplast can be used to generate ATP without concomitant reduction of NADP or other electron acceptors. Energised electrons are passed from PS I to ferredoxin and thence along a chain of electron carriers and back to the reaction centre of PS I, generating ATP en route. (18 Nov 1997) |
| cyclic strabismus | A strabismus that appears and disappears in rhythym, most frequently at 48-hour intervals. (05 Mar 2000) |
| cyclic uridine 3',5'-monophosphate | A cyclic nucleotide involved in metabolic regulation; inhibits the growth of some tumours. (05 Mar 2000) |
| hydrocarbons, cyclic | Organic compounds composed exclusively of carbon and hydrogen forming a closed ring that may be either alicyclic or aromatic. (12 Dec 1998) |
| dibutyryl cyclic AMP | An analogue of cyclic AMP that shares some of the pharmacological effects of this nucleotide, but is generally believed to enter cells more readily on account of its greater hydrophobicity. (18 Nov 1997) |
| dibutyryl cyclic GMP | <chemical> N-(1-oxobutyl)-cyclic 3',5'-(hydrogen phosphate)-2'-butanoate guanosine. A derivative of cyclic GMP. It has a higher resistance to extracellular and intracellular phosphodiesterase than cyclic GMP. Chemical name: Guanosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate (12 Dec 1998) |
| inositol cyclic 1,2-phosphate 1-phosphodiesterase | <enzyme> Converts inositol 1:2-cyclic phosphate to inositol 2-phosphate; do not confuse with inositol 1,2 cyclic-phosphate 2-phosphohydrolase see annexin III Registry number: EC 3.1.4.- Synonym: cins(1,2)p hydrolase II (26 Jun 1999) |
| ethers, cyclic | Compounds of the general formula r-o-r arranged in a ring or crown formation. (12 Dec 1998) |
| 3',5'-cyclic AMP synthetase | <enzyme> Enzyme responsible for the ATP. (06 May 1997) |
| 3',5'-cyclic-GMP phosphodiesterase | <enzyme> An enzyme that catalyses the hydrolysis of cyclic GMP to yield guanosine-5'-phosphate. Chemical name: 3',5'-Cyclic-GMP 5'-nucleotidohydrolase Registry number: EC 3.1.4.35 (12 Dec 1998) |
| 8-bromo cyclic adenosine monophosphate | <chemical> 8-bromoadenosine cyclic 3',5'-(hydrogen phosphate). A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase. Chemical name: Adenosine, 8-bromo-, cyclic 3',5'-(hydrogen phosphate) (12 Dec 1998) |
| acetoacetyl-acyl carrier protein synthase | <enzyme> E coli enzyme, that catalyses condensation of malonyl-acyl carrier protein plus acetyl-acyl carrier protein; not inhibited by cerulenin Registry number: EC 2.3.1.- Synonym: acetoacetyl-acp synthase (26 Jun 1999) |
| acid soluble spore protein | <molecular biology> A DNA binding protein in the spores of some bacteria, thought to stabilise the DNA in an A configuration, so protecting it from cleavage by enzymes or UV light. (18 Nov 1997) |
| acute-phase protein | <haematology> These plasma proteins (in addition to fibrinogen) increase 25% or more in response to inflammation and injury are under direct control of interleukin-6 (IL-6) (hepatocyte-stimulating factor). Other proteins which increase are ceruloplasmin, C3 and C4 which increase 50% or more; alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin and fibrinogen (the major determinant of viscosity 1 ) which increase two- to fourfold; C-reactive protein (CRP) and serum amyloid A which increase several hundred-fold. Despite long-held clinical opinion to the contrary, available data indicate that neither ESR nor measurement of specific acute-phase reactants are useful in excluding underlying infection or inflammation regardless of the pretest probability. These proteins are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. They can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumour markers. See also: amyloid, c-reactive protein, erythrocyte sedimentation rate, viscosity. (25 Jun 1999) |